Navigation path

EUROPRISE


HIV/AIDS

European Vaccines and Microbicides Enterprise
Framework programme:
6
Call:
4
Project number:
LSHP-CT-2006-037611
EC contribution:
€ 15,500,000
Duration:
60 Months
Type:
NoE
Starting date:
1 January 2007

Keywords: HIV, AIDS, Vaccine, Microbicide, Mucosal, Network and Prevention

Summary:

The successful development of preventative strategies against HIV-1 infection (microbicides, vaccines or their combined effects) would provide a pivotal turning point in global efforts to combat the pandemic spread of AIDS providing an incalculable impact on solving societal prob-lems associated with this disease. The principal aim of this project is to bring together EU scien-tists from the microbicide and vaccine fields to embrace a co-ordinated approach to HIV-1 infec-tion prevention research. Partners in the EUROPRISE consortium represent 13 projects funded by the European Commission from the sixth Framework Programme as well as four projects funded by the Gates Foundation.

These projects involve 132 institutions from 22 countries. EUROPRISE is, in this respect, the first consortium to purposely bring these groups together in a truly integrated fashion from both within Europe and internationally. EUROPRISE will offer an integrated programme of research; co-ordinate a wide portfolio of activities and encompass the whole pipeline of vaccine and microbicide development; from early discovery, through to early clinical trials. This unique approach places the Network at the international forefront, for understanding the interface between these two technologies; pursuing a critical path to the develop-ment of effective HIV-1 infection prevention strategies.

[+] Read More